Laura Bankhead
Family · Houston, TXNPI 1629622618
Payments from drug & device makers
Across 45 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$280
- Sage Therapeutics, LLC$107
- Lilly USA, LLC$105
- Exeltis, USA Inc.$72
- Exact Sciences$60
- Organon$58
- plus $223 from 9 others
What the payments were for
- Food & beverage$904100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 17 | $280 |
| Sage Therapeutics, LLC | 6 | $107 |
| Lilly USA, LLC | 1 | $105 |
| Exeltis, USA Inc. | 4 | $72 |
| Exact Sciences | 3 | $60 |
| Organon | 2 | $58 |
| Evofem Biosciences, Inc. | 3 | $57 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Avion Pharmaceuticals | 1 | $24 |
| Coopersurgical, Inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| Millicent US Inc | 1 | $20 |
| Novo Nordisk | 1 | $16 |
| Optumhealth Care Solutions, LLC | 1 | $16 |
| Shield Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$105
How this compares
$904 in reported general payments places this provider in the 65th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Houston
- Lashonda CraneHouston$3.4M
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- David WeirDallas$959K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.